Abiopharma

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026

AZN new Head of Investor Relations Joris Silon

Organon & Co. - Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway

Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants

SCENESSE® efficacy in vitiligo: new cases presented at RDTC Conference

Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference